Targeting headaches and tumors with nano-submarines

Scientists at the Mainz University Medical Center and the Max Planck Institute for Polymer Research (MPI-P) have developed a new method to enable miniature drug-filled nanocarriers to dock on to immune cells, which in turn attack tumors. In the future, this may lead to targeted treatment that can largely eliminate damage to healthy tissue. The scientists have recently published their findings in the renowned scientific journal Nature Nanotechnology.

Professor Volker Mailänder and his team from the Department of Dermatology at the University Medical Center of Johannes Gutenberg University Mainz (JGU) have recently developed an ingenious new of binding antibodies to such drug capsules. “Up to now, we have always had to use elaborate chemical methods to bind these antibodies to nanocapsules,” explained Mailänder. “We have now been able to show that all that you need to do is to combine antibodies and nanocapsules together in an acidified solution.”

Read more at phys.org

Image Credit:  Stefan Schuhmacher 

News This Week

Laboratory’s nanopore research hits a nerve

Since the discovery of biological ion channels and their role in physiology, scientists have attempted to create man-made structures that mimic their biological counterparts. New research by Lawrence Livermore National Laboratory (LLNL) scientists and [...]

2018-07-23T13:53:14+00:00

Leave A Comment